Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
14.07
-0.13 (-0.92%)
Nov 4, 2024, 4:00 PM EST - Market closed
Rigel Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 248 | 253 | 259 | 453 | 591 | 359 | |
Market Cap Growth | -35.58% | -2.48% | -42.79% | -23.38% | 64.89% | -6.41% | |
Enterprise Value | 301 | 295 | 269 | 403 | 560 | 289 | |
Last Close Price | 14.20 | 14.50 | 15.00 | 26.50 | 35.00 | 21.40 | |
PE Ratio | - | -10.06 | -4.42 | -25.22 | -19.86 | -5.35 | |
PS Ratio | 1.91 | 2.18 | 2.24 | 3.27 | 5.44 | 6.05 | |
PB Ratio | -4.82 | -8.83 | -19.04 | 14.92 | 17.38 | 6.67 | |
P/FCF Ratio | -11.72 | -44.03 | -3.49 | 86.30 | -11.07 | -8.35 | |
P/OCF Ratio | -11.72 | -44.03 | -3.51 | 77.10 | -11.33 | -8.64 | |
EV/Sales Ratio | 2.31 | 2.55 | 2.33 | 2.90 | 5.15 | 4.88 | |
EV/EBITDA Ratio | -26.10 | -14.49 | -4.66 | -21.98 | -19.80 | -4.23 | |
EV/EBIT Ratio | -21.52 | -13.66 | -4.59 | -20.67 | -19.32 | -4.19 | |
EV/FCF Ratio | -15.94 | -51.34 | -3.63 | 76.67 | -10.47 | -6.74 | |
Debt / Equity Ratio | -3.35 | -3.64 | -6.44 | 3.00 | 1.15 | 0.67 | |
Debt / FCF Ratio | -8.15 | -18.14 | -1.18 | 17.38 | -0.73 | -0.85 | |
Asset Turnover | 1.06 | 0.92 | 0.77 | 1.00 | 0.84 | 0.41 | |
Inventory Turnover | 2.86 | 2.17 | 5.17 | 10.82 | 12.21 | 20.50 | |
Quick Ratio | 1.33 | 1.64 | 1.51 | 2.21 | 1.79 | 1.86 | |
Current Ratio | 1.62 | 1.86 | 1.78 | 2.43 | 2.18 | 2.04 | |
Return on Equity (ROE) | - | - | -699.05% | -55.63% | -67.72% | -81.73% | |
Return on Assets (ROA) | -4.64% | -10.73% | -24.34% | -8.77% | -14.04% | -30.13% | |
Return on Capital (ROIC) | -7.73% | -18.03% | -37.50% | -12.50% | -22.19% | -43.18% | |
Earnings Yield | -5.70% | -9.92% | -22.59% | -3.95% | -5.03% | -18.65% | |
FCF Yield | -4.93% | -2.27% | -28.62% | 1.16% | -9.04% | -11.98% | |
Buyback Yield / Dilution | -0.93% | -0.93% | -1.12% | -1.03% | -0.81% | -4.28% | |
Total Shareholder Return | -0.93% | -0.93% | -1.12% | -1.03% | -0.81% | -4.28% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.